Extracellular matrix modulating agent

MYPI2025004123A0Undetermined Publication Date: 2020-08-28KOWA CO LTD +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025004123
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-09-30
Filing Date
2020-02-27
Publication Date
2020-08-28
Patent Text Reader

Abstract

The present invention provide an agent for modulating expression of extracellular matrix by corneal endothelial cells. The present invention pertains to an agent for modulating expression of extracellular matrix by corneal endothelial cells containing, 1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof, or a solvate thereof. Figure 1
Need to check novelty before this filing date? Find Prior Art